Status:

ENROLLING_BY_INVITATION

Does BCG Vaccination Reduce Biomarkers of Alzheimer's Disease?

Lead Sponsor:

Tamir Ben-Hur

Collaborating Sponsors:

Hebrew University of Jerusalem

Conditions:

Alzheimer Disease, Late Onset

Eligibility:

All Genders

70-80 years

Phase:

EARLY_PHASE1

Brief Summary

The goal of this clinical trial is to test whether vaccination with the BCG vaccine may improve the blood level of a biomarker of Alzheimer's disease (AD) in participants who are cognitively- and func...

Detailed Description

Brain accumulation of insoluble Beta-Amyloid and of hyperphosphorylated tau protein -rich neurofibrillary tangles in Alzheimer's disease (AD), accompanied by oxidative stress and sustained inflammatio...

Eligibility Criteria

Inclusion

  • 70-80 years old patients with self-reported preserved cognitive function and instrumental activities of daily life (iADL).
  • MoCA score of ≥26.
  • Increased plasma p-tau181 level.

Exclusion

  • Extrapyramidal signs, documented CVA, existence of multi-infarct dementia or fronto-temporal dementia according to clinical impression by treating cognitive neurologist.
  • Active cancer, severe cardio-pulmonary disease or other medical condition which negatively affects ability to evaluate patients and complete follow-up.
  • Active glucocorticoids treatment, chronic immunosuppressive medications, or currently living with an immunosuppressed individual to prevent an adverse event from the administration of this live vaccine.
  • Above 10mm induration diameter at 48 hours after initial PPD test.
  • Inability to sign an informed consent due to psychiatric or dementing condition.

Key Trial Info

Start Date :

July 1 2023

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 31 2025

Estimated Enrollment :

60 Patients enrolled

Trial Details

Trial ID

NCT06078891

Start Date

July 1 2023

End Date

December 31 2025

Last Update

March 18 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Department of Neurology, Hadassah medical Center

Jerusalem, Israel